Clinical Trials Register

Trials with a EudraCT protocol (7,058)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

7,058 result(s) found for: Prior Placebo. Displaying page 353 of 353.

EudraCT Number: 2018-000849-38

Sponsor Protocol Number: 208851

Start Date*: 2018-12-14

Sponsor Name:GlaxoSmithKline Biologicals

Full Title: A Phase I/II, randomized, placebo-controlled, observer-blind, multicenter study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ investigational respiratory syncytial v...

Medical condition: Volunteers (Active immunisation for the prevention of disease caused by respiratory syncytial virus (RSV) in adults aged 60 years or above)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10021881 - Infections and infestations	10038718	Respiratory syncytial virus bronchiolitis	PT
	20.1	10021881 - Infections and infestations	10061603	Respiratory syncytial virus infection	PT
	20.1	10021881 - Infections and infestations	10035692	Pneumonia due to respiratory syncytial virus	LLT
	20.1	10021881 - Infections and infestations	10052200	Respiratory syncytial virus infection NOS	LLT
	20.1	10021881 - Infections and infestations	10066741	Respiratory syncytial virus infection recurrent	LLT
	20.1	10021881 - Infections and infestations	10067384	Respiratory syncytial virus pneumonitis	LLT
	20.1	10021881 - Infections and infestations	10069811	Respiratory syncytial virus bronchitis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

EudraCT Number: 2009-010939-40

Sponsor Protocol Number: PLEASE

Start Date*: 2010-04-29

Sponsor Name:UMCN St Radboud

Full Title: PLEASE Persistent Lyme Empiric Antibiotic Study Europe. A prospective, randomised study comparing two prolonged oral antibiotic strategies after initial intravenous ceftriaxone therapy for patients...

Medical condition: Persistent Lyme disease Persistent borreliosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10025169	Lyme disease	LLT
	12.0		10025170	Lyme's disease	LLT
	12.0		10067559	Lyme borreliosis	LLT
	12.0		10006036	Borrelia burgdorferi infection	LLT
	12.0		10061591	Borrelia infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Completed)

Trial results: View results

EudraCT Number: 2012-002856-18

Sponsor Protocol Number: RB12.079

Start Date*: 2013-03-22

Sponsor Name:CHRU de Brest

Full Title: ALdosterone antagonist Chronic HEModialysis Interventional Survival Trial

Medical condition:

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	100000004857	10050441	Chronic renal insufficiency	LLT
	14.1	10007541 - Cardiac disorders	10007649	Cardiovascular disorder	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing) BE (Completed)

Trial results: (No results available)

EudraCT Number: 2020-005602-26

Sponsor Protocol Number: FL-101-2001

Start Date*: 2021-08-03

Sponsor Name:Flame Biosciences

Full Title: A Two-cohort, Phase 2 Study of FL-101 as Neoadjuvant Therapy in Patients with Surgically Resectable Non-Small Cell Lung Cancer

Medical condition: Surgically resectable non-small cell lung cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029517	Non-small cell lung cancer stage I	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029518	Non-small cell lung cancer stage II	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029520	Non-small cell lung cancer stage IIIA	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Prematurely Ended) NL (Prematurely Ended)

Trial results: View results

EudraCT Number: 2018-001857-29

Sponsor Protocol Number: V130_14

Start Date*: 2019-03-13

Sponsor Name:Seqirus UK Limited

Full Title: A Phase III, Randomized, Observer-blind, Multicenter Study to Evaluate the Efficacy, Immunogenicity and Safety of Seqirus' Cell-Based Quadrivalent Subunit Influenza Virus Vaccine (QIVc) Compared to...

Medical condition: Prophylaxis of influenza virus infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10021881 - Infections and infestations	10022000	Influenza	PT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: BG (Completed) EE (Completed) CZ (Completed) LV (Completed) PL (Completed) Outside EU/EEA RO (Ongoing)

Trial results: View results

EudraCT Number: 2011-000456-42

Sponsor Protocol Number: GS-US-256-0148

Start Date*: 2011-10-04

Sponsor Name:Gilead Sciences Inc.

Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Response Guided Therapy with GS 5885 Alone or in Combination with GS-9451 with Peginterferon Alfa 2a and Ribavirin in Treat...

Medical condition: Genotype 1 Hepatitis C Virus Infection

Disease:	Version	SOC Term	Classification Code	Term	Level
	13.1	10021881 - Infections and infestations	10021881	Infections and infestations	SOC
	13.1	10021881 - Infections and infestations	10019744	Hepatitis C	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) CZ (Completed) HU (Completed) BG (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2009-015198-11

Sponsor Protocol Number: B1971014(6108A1-3003)

Start Date*: 2011-07-01

Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017

Full Title: A Phase 3, Randomized, Active-Controlled, Observer-Blinded Trial to Assess the Safety and Tolerability of a Meningococcal Serogroup B Bivalent Recombinant Lipoprotein (rLP2086) Vaccine Given in Hea...

Medical condition: Bacterial Meningitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004862	10004049	Bacterial meningitis	LLT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: SE (Completed) CZ (Completed) LT (Completed) EE (Completed) FI (Completed) DK (Completed) ES (Completed) DE (Completed) Outside EU/EEA

Trial results: View results

EudraCT Number: 2008-008447-26

Sponsor Protocol Number: CQAB149B2351

Start Date*: 2009-03-02

Sponsor Name:Novartis Pharma Services AG

Full Title: A randomized, double-blind, controlled, parallel group, 12-week treatment study to compare the efficacy and safety of the combination of indacaterol 150 μg once daily with open label tiotropium 18 ...

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Completed) SK (Completed) HU (Completed) ES (Completed) CZ (Completed)

Trial results: View results

EudraCT Number: 2007-007107-32

Sponsor Protocol Number: M10-301

Start Date*: 2009-07-31

Sponsor Name:Abbott GmbH & Co. KG

Full Title: A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study of Carboplatin /Paclitaxel in Combination with ABT-869 Versus Carboplatin/Paclitaxel Alone in Subjects with Advanced or Metastatic Non-S...

Medical condition: Non small cell lung cancer.

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10029514	Non-small cell lung cancer NOS	LLT
	9.1		10029515	Non-small cell lung cancer recurrent	LLT
	9.1		10059515	Non-small cell lung cancer metastatic	LLT
	9.1		10029516	Non-small cell lung cancer stage 0	LLT
	9.1		10029517	Non-small cell lung cancer stage I	LLT
	9.1		10029518	Non-small cell lung cancer stage II	LLT
	9.1		10029519	Non-small cell lung cancer stage III	LLT
	9.1		10029520	Non-small cell lung cancer stage IIIA	LLT
	9.1		10029521	Non-small cell lung cancer stage IIIB	LLT
	9.1		10029522	Non-small cell lung cancer stage IV	PT
	9.1		10059515	Non-small cell lung cancer metastatic	PT
	9.1		10029515	Non-small cell lung cancer recurrent	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2007-002218-21

Sponsor Protocol Number: 0431-068

Start Date*: 2008-01-03

Sponsor Name:Merck & Co., Inc.

Full Title: A Phase III Randomized, Active-Comparator (Pioglitazone) Controlled Clinical Trial to Study the Efficacy and Safety of Sitagliptin and MK-0431A (A Fixed-DOse Combination Tablet of Sitagliptin and M...

Medical condition: type II diabetes mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) IS (Completed) IT (Completed) SI (Completed) GR (Completed)

Trial results: View results

EudraCT Number: 2007-004076-38

Sponsor Protocol Number: 511.118

Start Date*: 2007-11-30

Sponsor Name:Boehringer Ingelheim France

Full Title: A Twenty Eight –Week, Open-Label, Safety Study of Flibanserin 50 milligrams to 100 milligrams dailyin Premenopausal European Women With Hypoactive Sexual Desire Disorder

Medical condition: Primary generalized acquired Hypoactive Sexual Desire Disorder in Premenopausal women

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10020933	Hypoactive sexual desire disorder	LLT

Population Age: Adults

Gender: Female

Trial protocol: FR (Completed) NL (Completed) FI (Completed) BE (Completed) ES (Completed) CZ (Completed) SE (Completed) GB (Completed) AT (Prematurely Ended) HU (Completed) IT (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2015-001605-14

Sponsor Protocol Number: CCR4309

Start Date*: 2015-07-21

Sponsor Name:The Royal Marsden NHS Foundation Trust

Full Title: A Randomised, double-blind, placebo controlled, multi-centre phase II study to assess the Efficacy and safety of 2nd line Olaparib in combination with Paclitaxel, in Western patients with advanced ...

Medical condition: Advanced Gastric and Gastro-oesophageal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017758	Gastric cancer	PT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10062878	Gastrooesophageal cancer	PT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10063916	Metastatic gastric cancer	PT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017760	Gastric cancer NOS	LLT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017768	Gastric cancer stage IV without metastases	LLT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066350	Adenocarcinoma of the gastrooesophageal junction	LLT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017761	Gastric cancer recurrent	PT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017766	Gastric cancer stage IV NOS	LLT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061967	Gastric cancer stage IV	PT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017767	Gastric cancer stage IV with metastases	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2015-004844-20

Sponsor Protocol Number: ADXS001-02

Start Date*: 2017-05-08

Sponsor Name:Advaxis, Inc

Full Title: Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV (Advaxis IMmunotherapy 2 prevent CERVical recurrence)

Medical condition: High-risk locally advanced carcinoma of the cervix (HRLACC) following concurrent chemotherapy and radiation therapy.

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.1	100000004864	10008231	Cervical cancer recurrent	LLT
	19.1	100000004864	10008229	Cervical cancer	LLT
	19.1	100000004864	10008236	Cervical cancer stage IV	LLT
	19.1	100000004864	10008235	Cervical cancer stage III	LLT
	19.1	100000004864	10008234	Cervical cancer stage II	LLT
	19.1	100000004864	10008233	Cervical cancer stage I	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Prematurely Ended) PL (Completed)

Trial results: View results

EudraCT Number: 2016-003268-37	Sponsor Protocol Number: 205239	Start Date*: 2018-09-26
Sponsor Name:GlaxoSmithKline Biologicals SA
Full Title: A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine when...
Medical condition: Healthy subjects (to assess the safety and immunogenicity of Bexsero and Prevnar13 when administered concomitantly with RIV to healthy infants).
Disease:
Population Age: Infants and toddlers, Under 18		Gender: Male, Female
Trial protocol: Outside EU/EEA
Trial results: (No results available)

EudraCT Number: 2010-018562-23

Sponsor Protocol Number: 6078-PG-PSC-169

Start Date*: 2010-09-15

Sponsor Name:LETI Pharma GmbH

Full Title: A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum in Patients with Allergic Rhinitis and/or Rhinoconjunctivi...

Medical condition: Allergic rhinitis and/or allergic rhinoconjunctivitis with or without intermittent asthma.

Disease:	Version	SOC Term	Classification Code	Term	Level
	13.1	10015919 - Eye disorders	10001728	Allergic rhinoconjunctivitis	LLT
	13.1	10038738 - Respiratory, thoracic and mediastinal disorders	10001723	Allergic rhinitis	LLT
	13.1	10038738 - Respiratory, thoracic and mediastinal disorders	10001705	Allergic asthma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Prematurely Ended) BG (Ongoing) HU (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2010-019262-86

Sponsor Protocol Number: LTS11210

Start Date*: 2011-06-22

Sponsor Name:sanofi-aventis Recherche & Développement

Full Title: Estudio de extensión multicéntrico no controlado que evalúa la eficacia y seguridad de SAR153191 junto con Fármacos Anti-Reumáticos Modificadores de la Enfermedad (FARMEs) en pacientes con Artritis...

Medical condition: Artritis Reumatoide _______________________ Rheumatoid Arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10039073	Rheumatoid arthritis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) FI (Completed) EE (Completed) HU (Completed) NL (Completed) DE (Completed) GR (Completed) NO (Completed) LT (Completed) CZ (Completed) IT (Completed) AT (Completed) PT (Completed) SK (Completed) GB (GB - no longer in EU/EEA) BE (Completed) SE (Completed)

Trial results: View results

EudraCT Number: 2008-003640-11

Sponsor Protocol Number: MK0431C-102

Start Date*: 2008-10-30

Sponsor Name:MERCK & CO., INC.

Full Title: A Multicenter, Randomized, Double-Blind Study of the Co-Administration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control.

Medical condition: Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10049746	Insulin-requiring type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) SI (Completed) AT (Completed) LT (Completed) EE (Completed) LV (Completed) GR (Completed) BG (Completed)

Trial results: View results

EudraCT Number: 2008-008135-28

Sponsor Protocol Number: 01-281108

Start Date*: 2009-04-16

Sponsor Name:Hull and East Yorkshire NHS Hospitals Trust

Full Title: Effect of Sildenafil on Pulmonary Artery Pressure during hypoxia and exercise in Chronic Heart Failure

Medical condition: We will investigate the effect of sildenafil on pulmonary artery pressure in Heart failure patients (impaired heart function). Patients will be recruited from the Heart Failure clinic at Castle Hil...

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10002034	Anaemia	LLT
	9.1		10040756	Sinusitis NOS	LLT
	9.1		10016807	Fluid retention	LLT
	9.1		10022437	Insomnia	LLT
	9.1		10016998	Forehead headache	LLT
	9.1		10010108	Common migraine	LLT
	9.1		10002855	Anxiety	LLT
	9.1		10044565	Tremor	LLT
	9.1		10033987	Paresthesia	LLT
	9.1		10006790	Burning sensation NOS	LLT
	9.1		10020937	Hypoaesthesia	LLT
	9.1		10007882	Cellulitis	LLT
	9.1		10022000	Influenza	LLT
	9.1		10038870	Retinal hemorrhage	LLT
	9.1		10047544	Visual disturbance NOS	LLT
	9.1		10047513	Vision blurred	LLT
	9.1		10034960	Photophobia	LLT
	9.1		10008795	Chromatopsia	LLT
	9.1		10051819	Cyanopsia	LLT
	9.1		10015910	Eye blood shot	LLT
	9.1		10015946	Eye irritation	LLT
	9.1		10038189	Red eye	LLT
	9.1		10047531	Visual acuity reduced	LLT
	9.1		10013036	Diplopia	LLT
	9.1		10000173	Abnormal sensation in eye	LLT
	9.1		10047340	Vertigo	LLT
	9.1		10065027	Sudden deafness	LLT
	9.1		10016825	Flushing	LLT
	9.1		10006461	Bronchitis NOS	LLT
	9.1		10015090	Epistaxis	LLT
	9.1		10039092	Rhinitis NOS	LLT
	9.1		10011224	Cough	LLT
	9.1		10028735	Nasal congestion	LLT
	9.1		10012735	Diarrhoea	LLT
	9.1		10013946	Dyspepsia	LLT
	9.1		10017869	Gastritis NOS	LLT
	9.1		10017888	Gastroenteritis	LLT
	9.1		10017885	Gastrooesophageal reflux disease	LLT
	9.1		10019022	Haemorrhoids	LLT
	9.1		10000060	Abdominal distension	LLT
	9.1		10013781	Dry mouth	LLT
	9.1		10001760	Alopecia	LLT
	9.1		10015150	Erythema	LLT
	9.1		10029410	Night sweats	LLT
	9.1		10040913	Skin rash	LLT
	9.1		10028411	Myalgia	LLT
	9.1		10003988	Back pain	LLT
	9.1		10018800	Gynaecomastia	LLT
	9.1		10036661	Priapism	LLT
	9.1		10052791	Erection increased (excl priapism)	LLT
	9.1		10037660	Pyrexia	LLT
	9.1		10042438	Sudden hearing loss, unspecified	LLT
	9.1		10033425	Pain in extremity	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Prior Placebo